Manufacture

The FDA approval of Kymriah marks the first CAR-T cell-based gene therapy available in the US

What does “manufacturing” drugs in the body mean for chemotherapy?

New analytical techniques could be used alongside old ones to get the best of both worlds

This issue marks The Medicine Maker's third birthday!

Sitting down with Steve Oh from the Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR

When it comes to cryopreserving cell therapies, there's a right way - and a wrong way…

As fast as gene therapies are progessing, there's still one major hurdle to overcome: cost

To effectively develop advanced therapies, you need the right supply chain management

We need to stop companies from using loopholes to sell unproven cell therapies to desperate patients

A handful of cell- and gene-based therapies have now been approved, and more are sure to follow.